Recent posts

TypePostAuthorRepliesLast updated
Blog entryWIPO General Assembly 2016: Opening statement of Chile on behalf of the Group of Latin and the Caribbean Group (GRULAC) thiru015 weeks 1 day ago
Blog entrySCP24:WIPO patent committee adopts robust work program on patents and health, limitations and exceptions and quality of patents thiru015 weeks 6 days ago
Blog entryUSPTO publishes new estimates of "IP-Intensive" industries, spin results James Love016 weeks 15 hours ago
PageAndrew S. Goldman, Counsel, Policy and Legal Affairs Claire Cassedy016 weeks 18 hours ago
Blog entryNational Association of Manufacturers told USTR the EU position on LDC extension made a mockery of international trading system thiru016 weeks 4 days ago
Blog entryDifferences between the march-in, royalty free right, and government use options James Love016 weeks 4 days ago
PageDiane Singhroy, Scientific and Technical Advisor Claire Cassedy016 weeks 5 days ago
Blog entry500+ Pages of Documents on NFL Attempts to Influence NIH Funding of Concussion Studies Zack Struver016 weeks 6 days ago
Blog entryNIH Waivers for U.S. Manufacturing Requirements for Federally-Funded Drugs Zack Struver017 weeks 18 hours ago
Blog entryKEI Statement on United Nations Secretary-General's High-Level Panel on Access to Medicines Report KEI Staff017 weeks 3 days ago
Blog entryCancer Moonshot Blue Ribbon Panel Does Not Address Pricing, Alternative Funding Models Zack Struver017 weeks 3 days ago
Blog entrySummary of Report of United Nations Secretary-General's High-Level Panel on Access to Medicines Zack Struver017 weeks 4 days ago
Blog entryTRIPS Council (October 2014): India calls for de-linkage and innovation inducement prizes at WTO discussions on IP & innovation thiru017 weeks 5 days ago
Blog entryWIPO Marrakesh Treaty for the blind to come into force September 30, 2016, following ratification by Canada James Love018 weeks 3 days ago
Blog entryGerman Court Issues Compulsory License on HIV Drug Patent Andrew Goldman018 weeks 3 days ago
Blog entryCommentary on Hillary Clinton's Plan to Respond to Unjustified Price Hikes for Long-Available Drugs Claire Cassedy018 weeks 5 days ago
Blog entryKEI Briefing Note 2016:2: 2015-2016 Pharmaceutical Transparency Legislation Zack Struver018 weeks 6 days ago
Book pagePublications and Research Notes James Love018 weeks 6 days ago
Blog entry2016: KEI/MSF comments to NIH on licensing of patents on Attenuated Respiratory Syncytial Virus (RSV) Vaccines James Love020 weeks 3 days ago
Blog entryHarvoni & Sovaldi, Xtandi in Top 20 Costliest Medicare Drugs Zack Struver022 weeks 3 days ago
Blog entryBloomberg: CVS Will Exclude Xtandi From Formulary in 2017 Zack Struver023 weeks 6 days ago
Blog entryVivendi-SFR lobbyist nominated to WIPO Staff023 weeks 6 days ago
Blog entryProposal for a WTO Agreement on the Supply of Public goods KEI Staff024 weeks 3 days ago
Blog entryLetter from 56 non-profits and experts to Secretary of State John Kerry on pressure on global access to medicines initiatives Zack Struver024 weeks 5 days ago
Blog entryWIPO GA 2013 to decide on future of the Intergovernmental Committee on Genetic Resources, Traditional Knowledge and Folklore thiru024 weeks 5 days ago